President Donald Trump signed a sweeping executive order lowering prescription drug prices through a “Most Favored Nation” policy in a move that is legally dubious and is sure to face fierce opposition from pharmaceutical companies.

President Donald Trump announced Sunday that he plans to resurrect a controversial policy from his first term that aims to reduce drug costs by basing payments for certain medicines on their prices in other countries.